首页> 美国卫生研究院文献>Springer Open Choice >Lipid composition in a strain of Bacillus subtilis a producer of iturin A lipopeptides that are active against uropathogenic bacteria
【2h】

Lipid composition in a strain of Bacillus subtilis a producer of iturin A lipopeptides that are active against uropathogenic bacteria

机译:枯草芽孢杆菌菌株中的脂质成分它是抗尿毒症细菌活性的伊图林A脂肽生产者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AbstractUrinary tract infections are a common disease in humans. Therefore, new methods are needed to destroy biofilms that are formed by uropathogens. Iturin A lipopeptides (LPs) C14 and C15 are potent biosurfactants synthetized by the Bacillus subtilis I′1a strain. The biological activity of extracted LPs was confirmed by examining extracts from I′1a cultures against uropathogenic bacteria that had been isolated from biofilms on urinary catheters. Compared with cultures of DSM 3257, which produce surfactin at a relatively low level, the extract obtained from strain I′1a exhibited a greater inhibitory effect against both planktonic and sessile forms of Escherichia coli, Serratia marcescens, Enterobacter cloacae, Proteus mirabilis, Citrobacter freundii and Enterococcus faecalis. Moreover, cyclic LP biosurfactants may disturb the integrity of cytoplasmic membranes; therefore, we investigated the effects of synthetized LPs on fatty acids and phospholipids of B. subtilis. LPs and lipids were analyzed using GC–MS, LC–MS/MS and MALDI-TOF/TOF techniques. Compared with B. subtilis DSM 3257, membranes of the I′1a strain were characterized by an increased amount of anteiso fatty acids and a ten-fold higher ratio of phosphatidylglycerol (PG)-to-phosphatidylethanolamine (PE). Interestingly, in cultures of B. subtilis DSM 3257 supplemented with LP extracts of the I′1a strain, the PG-to-PE ratio was fourfold higher, and the amount of anteiso fatty acids was also increased.
机译:摘要尿路感染是人类的常见疾病。因此,需要新的方法来破坏由尿毒症形成的生物膜。 Iturin A脂肽(LPs)C14和C15是由枯草芽孢杆菌I'1a菌株合成的有效生物表面活性剂。通过检查I'1a培养物中的提取物针对从尿道导管上的生物膜中分离出的尿道致病菌,可以确认提取的LP的生物学活性。与产生较低表面活性素的DSM 3257培养物相比,从I'1a菌株获得的提取物对大肠杆菌,粘质沙雷氏菌,阴沟肠杆菌,变形杆菌,弗氏柠檬酸杆菌的浮游和无柄形式均表现出更大的抑制作用。和粪肠球菌。此外,环状LP生物表面活性剂可能会干扰细胞质膜的完整性。因此,我们研究了合成的LPs对枯草芽孢杆菌的脂肪酸和磷脂的影响。使用GC-MS,LC-MS / MS和MALDI-TOF / TOF技术分析LP和脂质。与枯草芽孢杆菌DSM 3257相比,I'1a菌株的膜特征在于前异脂肪酸含量增加,磷脂酰甘油(PG)与磷脂酰乙醇胺(PE)的比例高十倍。有趣的是,在补充I'1a菌株的LP提取物的枯草芽孢杆菌DSM 3257的培养物中,PG与PE的比率提高了四倍,并且前异脂肪酸的含量也增加了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号